Maeliloz Sinaasappel

Amylmetacresol, 2,4‑Dichlorobenzyl Alcohol and Lidocaine Hydrochloride, the active ingredients in Maeliloz Sinaasappel, are antiseptic and local‑anaesthetic agents presented as an oromucosal formulation for topical use. They provide symptomatic relief of sore throat and oral mucosal irritation in both adults and children. GNH USA supplies Maeliloz Sinaasappel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maeliloz Sinaasappel combines antiseptic and local‑anaesthetic action to address conditions of the oral cavity and pharynx. - Sore throat (pharyngitis): offers temporary pain relief and reduces microbial presence in the oropharynx. - Oral mucositis: eases discomfort and helps control secondary infection in chemotherapy‑induced mucosal lesions. - Minor mouth irritation (e.g., after dental procedures): provides rapid local anaesthesia and antiseptic protection.

Adverse reactions may occur with oromucosal exposure to the active ingredients.

Common Side Effects: - Transient oral numbness or tingling. - Mild taste alteration or metallic after‑taste. - Temporary irritation or burning sensation at the application site. - Nausea or mild gastrointestinal upset. - Headache.

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling, or angioedema. - Severe mucosal ulceration or necrosis. - Anaphylactic shock requiring immediate medical attention.

Before using Maeliloz Sinaasappel, consider the following safety measures. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Children: use only as directed and avoid excessive dosing. - Known hypersensitivity: do not use if allergic to any of the listed ingredients. - Concurrent use with other topical anaesthetics: monitor for additive numbness. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Potential drug interactions should be reviewed prior to therapy.

Major Interactions (Avoid): - Concurrent systemic administration of other local anaesthetics: may increase risk of systemic toxicity. - Use with alcohol‑based mouthwashes: can enhance mucosal irritation.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor for increased bleeding if oral lesions develop. - CYP450‑metabolised drugs: lidocaine may modestly affect metabolism of certain substrates. - Other antiseptic agents: assess cumulative antimicrobial effect to avoid dysbiosis.